High-Relaxivity Magnetic Resonance Imaging Contrast Agents Part 2: Optimization of Inner- and Second-Sphere Relaxivity

Rationale and Objectives:The observed relaxivity of gadolinium-based contrast agents has contributions from the water molecule(s) that bind directly to the gadolinium ion (inner-sphere water), long-lived water molecules and exchangeable protons that make up the second-sphere of coordination, and water molecules that diffuse near the contrast agent (outer-sphere). Inner- and second-sphere relaxivity can both be increased by optimization of the lifetimes of the water molecules and protons in these coordination spheres, the rotational motion of the complex, and the electronic relaxation of the gadolinium ion. We sought to identify new high-relaxivity contrast agents by systematically varying the donor atoms that bind directly to gadolinium to increase inner-sphere relaxivity and concurrently including substituents that influence the second-sphere relaxivity. Methods:Twenty gadolinium-1,4,7,10-tetraazacyclo-dodecane-N,N′,N″,N′″-tetraacetato derivatives were prepared and their relaxivity determined in presence and absence of human serum albumin as a function of temperature and magnetic field. Data was analyzed to extract the underlying molecular parameters influencing relaxivity. Each compound had a common albumin-binding group and an inner-sphere donor set comprising the 4 tertiary amine N atoms from cyclen, an &agr;-substituted acetate oxygen atom, 2 amide oxygen atoms, an inner-sphere water oxygen atom, and a variable donor group. Each amide nitrogen was substituted with different groups to promote hydrogen bonding with second-sphere water molecules. Results:Relativities at 0.47 and 1.4 T, 37°C, in serum albumin ranged from 16.0 to 58.1 mM−1s−1 and from 12.3 to 34.8 mM−1s−1, respectively. The reduction of inner-sphere water exchange typical of amide donor groups could be offset by incorporating a phosphonate or phenolate oxygen atom donor in the first coordination sphere, resulting in higher relaxivity. Amide nitrogen substitution with pendant phosphonate or carboxylate groups increased relaxivity by as much as 88% compared with the N-methyl amide analog. Second-sphere relaxivity contributed as much as 24 and 14 mM−1s−1 at 0.47 and 1.4 T, respectively. Conclusions:Water/proton exchange dynamics in the inner- and second-coordination sphere can be predictably tuned by choice of donor atoms and second-sphere substituents, resulting in high-relaxivity agents.

[1]  Claudio Luchinat,et al.  Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent. , 2007, Inorganic chemistry.

[2]  B. Jenkins,et al.  Site‐specific water proton relaxation enhancement of iron (III) chelates noncovalently bound to human serum albumin , 1991, Magnetic resonance in medicine.

[3]  A. Szabó,et al.  Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity , 1982 .

[4]  J. Kowalewski,et al.  Nuclear spin relaxation in paramagnetic systems (S>/=1) under fast rotation conditions. , 2003, Journal of magnetic resonance.

[5]  I. Solomon Relaxation Processes in a System of Two Spins , 1955 .

[6]  M. Port,et al.  A high-frequency EPR study of frozen solutions of Gd(III) complexes: straightforward determination of the zero-field splitting parameters and simulation of the NMRD profiles. , 2006, Journal of the American Chemical Society.

[7]  R. Dwek,et al.  The lanthanide cations as probes in biological systems. Proton relaxation enhancement studies for model systems and lysozyme. , 1971, European journal of biochemistry.

[8]  Peter Caravan,et al.  EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus. , 2008, Journal of the American Chemical Society.

[9]  Alain Borel,et al.  High relaxivity confined to a small molecular space: a metallostar-based, potential MRI contrast agent. , 2005, Angewandte Chemie.

[10]  Paul Jurek,et al.  Potentiometric and relaxometric properties of a gadolinium-based MRI contrast agent for sensing tissue pH. , 2007, Inorganic chemistry.

[11]  Peter Caravan,et al.  The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. , 2002, Journal of the American Chemical Society.

[12]  L. Helm,et al.  T1e in four Gd3+ chelates: LODEPR measurements and models for electron spin relaxation , 2002 .

[13]  Peter Caravan,et al.  Determination of the hydration number of gadolinium(III) complexes by high-field pulsed 17O ENDOR spectroscopy. , 2006, Chemphyschem : a European journal of chemical physics and physical chemistry.

[14]  H. Weinmann,et al.  In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. , 1991, Investigative radiology.

[15]  P. Anelli,et al.  Gd(DOTP)5‐ outer‐sphere relaxation enhancement promoted by nitrogen bases , 1993, Magnetic resonance in medicine.

[16]  T. Brady,et al.  Preparation and water relaxation properties of proteins labeled with paramagnetic metal chelates. , 1985, Magnetic resonance imaging.

[17]  Biplab Das,et al.  Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. , 2007, Angewandte Chemie.

[18]  Oleg G. Poluektov,et al.  High-field pulsed EPR and ENDOR of Gd3+ complexes in glassy solutions , 2005 .

[19]  Peter Caravan,et al.  High Relaxivity Magnetic Resonance Imaging Contrast Agents Part 1: Impact of Single Donor Atom Substitution on Relaxivity of Serum Albumin-Bound Gadolinium Complexes , 2010, Investigative radiology.

[20]  S. H. Koenig,et al.  Relaxation of solvent protons by paramagnetic ions and its dependence on magnetic field and chemical environment: implications for NMR imaging. , 1985, Magnetic resonance in medicine.

[21]  J. Serfaty,et al.  In Vivo Evaluation of a New Magnetic Resonance Imaging Contrast Agent (P947) to Target Matrix Metalloproteinases in Expanding Experimental Abdominal Aortic Aneurysms , 2010, Investigative radiology.

[22]  René M. Botnar,et al.  Molecular Magnetic Resonance Imaging of Myocardial Perfusion With EP-3600, a Collagen-Specific Contrast Agent: Initial Feasibility Study in a Swine Model , 2009, Circulation.

[23]  Peter Caravan,et al.  Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent. , 2008, Chemistry.

[24]  Joop A. Peters,et al.  Lanthanide(III) complexes of a mono(methylphosphonate) analogue of H4dota: the influence of protonation of the phosphonate moiety on the TSAP/SAP isomer ratio and the water exchange rate. , 2005, Chemistry.

[25]  Thomas J Meade,et al.  Bioresponsive, cell-penetrating, and multimeric MR contrast agents. , 2009, Accounts of chemical research.

[26]  E.,et al.  Paramagnetic Metal Complexes as Water Proton Relaxation Agents for NMR Imaging : Theory and Design , 2001 .

[27]  R Weissleder,et al.  A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. , 1993, Radiology.

[28]  Sherry,et al.  A Novel pH-Sensitive MRI Contrast Agent. , 1999, Angewandte Chemie.

[29]  P. Caravan,et al.  A High Relaxivity Magnetic Resonance Imaging Contrast Agent Targeted to Serum Albumin , 2008 .

[30]  Enzo Terreno,et al.  Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. , 2009, Accounts of chemical research.

[31]  Peter Caravan,et al.  Protein binding to lanthanide(III) complexes can reduce the water exchange rate at the lanthanide. , 2007, Inorganic chemistry.

[32]  A. Sautter,et al.  Photoinduced Electron and Energy Transfer Processes in a Bichromophoric Pyrene-Perylene Bisimide System , 2004 .

[33]  Peter Caravan,et al.  Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent. , 2004, Inorganic chemistry.

[34]  H. Thomsen,et al.  High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast Agent , 2008, Investigative radiology.

[35]  Elmar Spuentrup,et al.  Thrombus Imaging With Fibrin-Specific Gadolinium-Based MR Contrast Agent EP-2104R: Results of a Phase II Clinical Study of Feasibility , 2009, Investigative radiology.

[36]  L. Helm,et al.  Structural and Dynamic Parameters Obtained from 17O NMR, EPR, and NMRD Studies of Monomeric and Dimeric Gd3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach1 , 1996 .

[37]  S. Morcos,et al.  Nephrogenic Gadolinium Biodistribution and Skin Cellularity Following a Single Injection of Omniscan in the Rat , 2010, Investigative radiology.

[38]  K. Binnemans,et al.  Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies. , 2007, Dalton transactions.

[39]  Nicolaas Bloembergen,et al.  Proton Relaxation Times in Paramagnetic Solutions. Effects of Electron Spin Relaxation , 1961 .

[40]  X. Li,et al.  The Gd(3+) complex of a fatty acid analogue of DOTP binds to multiple albumin sites with variable water relaxivities. , 2001, Inorganic chemistry.

[41]  P. Furmanski,et al.  High-level conjugation of chelating agents onto immunoglobulins: use of an intermediary poly(L-lysine)-diethylenetriaminepentaacetic acid carrier. , 1986, Biochimica et biophysica acta.

[42]  René M. Botnar,et al.  Molecular MR Imaging of Human Thrombi in a Swine Model of Pulmonary Embolism Using a Fibrin-Specific Contrast Agent , 2007, Investigative radiology.

[43]  S. Rast,et al.  A general approach to the electronic spin relaxation of Gd(III) complexes in solutions. Monte Carlo simulations beyond the Redfield limit , 2001 .

[44]  Peter Caravan,et al.  Probing the water coordination of protein-targeted MRI contrast agents by pulsed ENDOR spectroscopy. , 2005, Chemphyschem : a European journal of chemical physics and physical chemistry.

[45]  E. Terreno,et al.  [DOTA-bis(amide)]lanthanide complexes: NMR evidence for differences in water-molecule exchange rates for coordination isomers. , 2001, Chemistry.

[46]  R. Lauffer,et al.  Targeted relaxation enhancement agents for MRI , 1991, Magnetic resonance in medicine.

[47]  Seymour H. Koenig,et al.  Field-cycling relaxometry of protein solutions and tissue: Implications for MRI , 1990 .

[48]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[49]  Oliver Kraff,et al.  Gadolinium-Based Magnetic Resonance Contrast Agents at 7 Tesla: In Vitro T1 Relaxivities in Human Blood Plasma , 2010, Investigative radiology.

[50]  Robert E Lenkinski,et al.  PARACEST agents: modulating MRI contrast via water proton exchange. , 2003, Accounts of chemical research.

[51]  Z. Kovács,et al.  Highly regioselective N-trans symmetrical diprotection of cyclen , 2006 .

[52]  J. Tacke,et al.  Molecular Magnetic Resonance Imaging of Deep Vein Thrombosis Using a Fibrin-Targeted Contrast Agent: A Feasibility Study , 2009, Investigative radiology.

[53]  C. Geraldes,et al.  First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity. , 2006, Contrast media & molecular imaging.

[54]  M. Ogan,et al.  Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. , 1987, Investigative radiology.

[55]  A. Sherry,et al.  Gd3+ Complexes with Slowly Exchanging Bound-Water Molecules May Offer Advantages in the Design of Responsive MR Agents , 2001, Investigative radiology.

[56]  Peter Caravan,et al.  Pulsed ENDOR Study of Water Coordination to Gd3+ Complexes in Orientationally Disordered Systems , 2004 .

[57]  V. Runge Gadolinium and nephrogenic systemic fibrosis. , 2009, AJR. American journal of roentgenology.

[58]  P C Lauterbur,et al.  Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents , 1994, Magnetic resonance in medicine.

[59]  L. Helm,et al.  Molecular dynamics simulations of MRI-relevant GdIII chelates: direct access to outer-sphere relaxivity. , 2001, Chemistry.

[60]  Peter Caravan,et al.  Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. , 2006, Chemical Society reviews.

[61]  S Aime,et al.  pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. , 2001, Journal of the American Chemical Society.

[62]  L. Helm,et al.  Inorganic and bioinorganic solvent exchange mechanisms. , 2005, Chemical reviews.